On the action of delta 9-tetrahydrocannabinol as an inhibitor of sodium- and potassium-dependent adenosine triphosphatase.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000818:Animals; D001921:Brain / Q000201:enzymology; D002286:Carcinoma, Ehrlich Tumor / Q000201:enzymology; D013759:Dronabinol / Q000494:pharmacology*; D004593:Electrophorus; D066298:In Vitro Techniques; D007700:Kinetics; D051379:Mice; D010101:Oxygen Consumption / Q000187:drug effects; D011188:Potassium / Q000378:metabolism; D051381:Rats; D012964:Sodium / Q000378:metabolism
D013759:Dronabinol; D012964:Sodium; D000251:Adenosine Triphosphatases; D011188:Potassium